Oral dydrogesterone treatment during the first trimester of pregnancy: The prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial

Author: Walch Katharina   Hefler Lukas   Nagele Friedrich  

Publisher: Informa Healthcare

ISSN: 1476-4954

Source: Journal of Maternal-Fetal and Neonatal Medicine, Vol.18, Iss.4, 2005-10, pp. : 265-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content